A detailed history of Monument Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Monument Capital Management holds 1,862 shares of ABT stock, worth $213,683. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,862
Previous 2,202 15.44%
Holding current value
$213,683
Previous $228,000 7.02%
% of portfolio
0.06%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$100.07 - $118.13 $34,023 - $40,164
-340 Reduced 15.44%
1,862 $212,000
Q2 2024

Jul 19, 2024

SELL
$100.73 - $112.44 $39,486 - $44,076
-392 Reduced 15.11%
2,202 $228,000
Q1 2024

Apr 18, 2024

BUY
$109.52 - $120.96 $5,695 - $6,289
52 Added 2.05%
2,594 $294,000
Q4 2023

Feb 01, 2024

BUY
$90.19 - $110.4 $229,262 - $280,636
2,542 New
2,542 $279,000
Q4 2022

Jan 26, 2023

BUY
$95.06 - $111.52 $203,618 - $238,875
2,142 New
2,142 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Monument Capital Management Portfolio

Follow Monument Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monument Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Monument Capital Management with notifications on news.